Curing Cancer by Mobilizing Your Natural Immune Defenses: The Revolution in Cancer Immunotherapy
The last 8 years have seen a revolution in approved cancer treatments, based on the development of medicines that arouse our immune systems to attack and eliminate our own cancer cells. These breakthroughs in immunotherapy of cancer were based on a deep understanding of the immune system itself, coupled with the first direct evidence that immune responses that attack human cancers occur naturally, albeit weakly. The treatments amplify natural immune responses against cancer, and are effective in some types of cancer, leading effectively to cures in many patients. They are less effective or not effective in many other types of cancer. The success has galvanized major new efforts by researchers and drug companies alike to develop complementary and more broadly effective medications to treat other types of cancer. The talk will describe how these medicines work, their current limitations, and the prospects for novel and more effective immunotherapy approaches, including those based on research in the speaker’s laboratory.
David H. Raulet
Director, Immunotherapy and Vaccine Research Initiative
Esther and Wendy Schekman Chair in Basic Cancer Biology
Professor, Department of Molecular and Cell Biology
OLLI @Berkeley Speaker Series events are free to current OLLI members and UC Berkeley faculty, staff, and students; $10 general admission. Registration is not required.